Merck & Co Inc

The U.S. Court of Appeals for the Federal Circuit has yet to rule on Classen Immunotherapies Inc.’s appeal from the dismissal of its patent infringement suit against Biogen Idec Inc,…

Schering-Plough Corp. and an entity jointly owned with Merck & Co., Inc. continue to pursue a patent infringement action against companies seeking approval of a generic version of ZETIA.

The action…